Ocugen, Inc. (OCGN)
1.05
+0.05
(+5.17%)
USD |
NASDAQ |
Sep 17, 11:18
Ocugen Price : 1.05 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 0.997 | 1.015 | 0.97 | 0.9984 | 9.094M |
| Sep 15, 2026 | 1.05 | 1.06 | 0.98 | 0.9935 | 12.65M |
| Sep 14, 2026 | 1.035 | 1.07 | 1.00 | 1.06 | 6.680M |
| Sep 11, 2026 | 1.04 | 1.06 | 1.01 | 1.02 | 6.471M |
| Sep 10, 2026 | 1.095 | 1.095 | 1.01 | 1.025 | 22.25M |
| Sep 09, 2026 | 1.31 | 1.320 | 1.06 | 1.065 | 39.26M |
| Sep 08, 2026 | 1.35 | 1.36 | 1.32 | 1.33 | 2.819M |
| Sep 04, 2026 | 1.32 | 1.38 | 1.31 | 1.36 | 3.568M |
| Sep 03, 2026 | 1.335 | 1.35 | 1.30 | 1.35 | 2.416M |
| Sep 02, 2026 | 1.34 | 1.38 | 1.31 | 1.32 | 4.285M |
| Sep 01, 2026 | 1.33 | 1.34 | 1.29 | 1.33 | 2.181M |
| Aug 31, 2026 | 1.315 | 1.34 | 1.28 | 1.33 | 4.663M |
| Aug 28, 2026 | 1.37 | 1.37 | 1.32 | 1.32 | 3.100M |
| Aug 27, 2026 | 1.42 | 1.42 | 1.36 | 1.37 | 2.904M |
| Aug 26, 2026 | 1.405 | 1.42 | 1.38 | 1.41 | 2.014M |
| Aug 25, 2026 | 1.39 | 1.43 | 1.38 | 1.40 | 4.595M |
| Aug 24, 2026 | 1.41 | 1.41 | 1.33 | 1.36 | 2.888M |
| Aug 21, 2026 | 1.41 | 1.42 | 1.37 | 1.39 | 2.447M |
| Aug 20, 2026 | 1.45 | 1.46 | 1.38 | 1.39 | 3.962M |
| Aug 19, 2026 | 1.38 | 1.49 | 1.35 | 1.48 | 6.883M |
| Aug 18, 2026 | 1.38 | 1.38 | 1.32 | 1.34 | 2.527M |
| Aug 17, 2026 | 1.34 | 1.38 | 1.32 | 1.375 | 2.501M |
| Aug 14, 2026 | 1.36 | 1.36 | 1.31 | 1.35 | 2.978M |
| Aug 13, 2026 | 1.41 | 1.44 | 1.34 | 1.35 | 3.922M |
| Aug 12, 2026 | 1.37 | 1.42 | 1.365 | 1.40 | 3.183M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.76 |
| Anika Therapeutics, Inc. | 21.20 |
| Gilead Sciences, Inc. | 148.90 |
| MannKind Corp. | 3.63 |
| Vertex Pharmaceuticals, Inc. | 514.59 |
Price Related Metrics
| PS Ratio | 73.51 |
| PEG Ratio | -0.1420 |
| Earnings Yield | -24.26% |
| Market Cap | 356.00M |
| PEGY Ratio | -0.1420 |